GSK Investigational Site

Suresnes 92151

1 studies enrolling now · 15 studies all time

What they study most

Asthma, Churg-Strauss Syndrome, Colonic Neoplasms, Eosinophilic Granulomatosis With Polyangiitis, Hypereosinophilia, Hypereosinophilic Syndrome, Infections, Urinary Tract, Neoplasms, Colon, Neoplasms, Prostate, Obstetric Labour, Premature, Prostatic Hyperplasia, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer — Recruiting now
• A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
• Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 — Completed
• A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 — Completed
• Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES) — Completed
• Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) — Completed
• Study to Evaluate Efficacy and Safety of Mepolizumab for Frequently Exacerbating Chronic Obstructive Pulmonary Disease (COPD) Patients — Completed
• A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) — Completed
• A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis — Completed
• The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor — Completed
• GSK2251052 in Complicated Urinary Tract Infection — Stopped early
• ARI103094-Follow-Up Study for REDUCE Study Subjects — Completed
• Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome — Stopped early
• Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed